Exchange: NASDAQ·Updated 09:40 AM EDT
HRMY logo

HRMYHarmony Biosciences Holdings Inc

$33.44
$0.06
(0.18%)
Today
EarningsAug 4
Mkt Cap$1.94B
Vol965.00
News
all
press releases
HRMY Posts Preliminary Q2 Revenues, Announces CFO Transition
Harmony Biosciences posts preliminary Q2 2026 Wakix revenues of about $261M, up 30% year over year, while reaffirming full-year guidance despite a CFO transition.
Zacks
News Placeholder
More News
News Placeholder
Harmony Biosciences Announces Preliminary Q2 Revenue, CFO Transition — Says Executive’s Departure Not Due To Any Disagreement
Harmony Biosciences announced the appointment of Stephen Mollichella, SVP and Controller, as Interim Principal Financial Officer to ensure continuity in financial leadership while it searches for a permanent CFO.
Stocktwits
News Placeholder
Wall Street Analysts See a 27.35% Upside in Harmony Biosciences (HRMY): Can the Stock Really Move This High?
The mean of analysts' price targets for Harmony Biosciences (HRMY) points to a 27.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks
News Placeholder
Zacks.com featured highlights Harmony, StoneCo, General Motors, Hewlett and Nexa
Harmony, StoneCo, General Motors, Hewlett and Nexa have been highlighted in this Screen of The Week article.
Zacks
News Placeholder
HRMY vs. AMGN: Which Stock Is the Better Value Option?
HRMY vs. AMGN: Which Stock Is the Better Value Option?
Zacks
News Placeholder
5 Low Price-to-Book Value Stocks to Buy in July for Solid Returns
Five low price-to-book stocks pass our value screens with low P/B, P/S and PEG metrics, highlighting their earnings growth potential.
Zacks
News Placeholder
Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks
News Placeholder
Best Value Stocks to Buy for July 14th
MEOH, LTM and HRMY made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 14th, 2026.
Zacks
News Placeholder
Is HRMY Stock Worth Buying With Neutral Signals and Cheap Valuation?
Harmony Biosciences trades at discounted valuations, but investors are weighing Wakix dependence, recent earnings misses and pipeline execution.
Zacks
News Placeholder
Harmony Biosciences Stock Outlook as Wakix Growth Meets Pipeline
Harmony Biosciences is leveraging Wakix growth to expand its neuroscience pipeline, while advancing pitolisant programs and rare disease assets.
Zacks
<
1
2
...
>

Advertisement|Remove ads.